Jiejun Du Selected Research

Imipenem Drug Combination Cilastatin (Primaxin)

12/2021	A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).
3/2020	Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study.
1/2020	Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections.
1/2017	Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiejun Du Research Topics

Disease

4	Infections 03/2020 - 01/2018
3	Bacterial Infections (Bacterial Infection) 03/2020 - 01/2020
2	Urinary Tract Infections (Urinary Tract Infection) 01/2020 - 01/2017
1	COVID-19 10/2022
1	Critical Illness (Critically Ill) 12/2021
1	Bacterial Pneumonia 12/2021
1	Acute Kidney Injury (Acute Renal Failure) 03/2020
1	Renal Insufficiency (Renal Failure) 03/2020
1	Gram-Negative Bacterial Infections 03/2020
1	Intraabdominal Infections 01/2020
1	Ventilator-Associated Pneumonia 01/2020
1	Insulin Resistance 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Chest Pain (Chest Pains) 01/2018
1	Cellulitis 01/2018
1	Opiate Overdose 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Pyelonephritis 01/2017

Drug/Important Bio-Agent (IBA)

5	relebactamIBA 12/2021 - 01/2017
4	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 12/2021 - 01/2017
4	Imipenem FDA Link 03/2020 - 01/2017
3	Colistin (Coly-Mycin)FDA Link 03/2020 - 01/2020
1	molnupiravirIBA 10/2022
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 12/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2020
1	Ribavirin (Virazole)FDA LinkGeneric 01/2018
1	CreatinineIBA 01/2018
1	grazoprevirIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	SofosbuvirIBA 01/2018
1	elbasvirIBA 01/2018

Therapy/Procedure

1	Mechanical Ventilators (Ventilator) 12/2021
1	Therapeutics 03/2020